Clinical Trials Logo

Clinical Trial Summary

The study aims the assessment of endothelial glycocalyx (EG) degradation in deceased organ donors. There is a lack of organs for the transplantation program. By the description of the EG status, we can open room for organ optimization before transplantation and improve the organ function after transplantation in marginal donors.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05609123
Study type Observational
Source University Hospital Hradec Kralove
Contact David Astapenko, MD, PhD
Phone +420495833218
Email david.astapenko@fnhk.cz
Status Recruiting
Phase
Start date January 1, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04789213 - Mortality, Morbidity and Risk Factors of Liver Retransplantation
Terminated NCT03439995 - Goal of Open Lung Ventilation in Donors N/A
Completed NCT02525510 - Deceased Organ Donor Interventions to Protect Kidney Graft Function N/A
Recruiting NCT05148715 - Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY) Phase 2